Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.16 HKD
−521.04 M HKD
371.52 M HKD
1.12 B
About MICROPORT CARDIOFLOW MEDTECH CORP
Sector
Industry
Headquarters
Shanghai
Website
Founded
2019
FIGI
BBG00Y4744W7
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. It offers research, development and commercialization of medical devices for valvular heart diseases. The firm provides services through its subsidiaries. The company was founded on January 10, 2019 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2160 is 0.70 HKD — it has decreased by −1.45% in the past 24 hours. Watch MICROPORT CARDIOFLOW MEDTECH CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange MICROPORT CARDIOFLOW MEDTECH CORP stocks are traded under the ticker 2160.
2160 stock has risen by 1.49% compared to the previous week, the month change is a −1.45% fall, over the last year MICROPORT CARDIOFLOW MEDTECH CORP has showed a −57.32% decrease.
2160 reached its all-time high on Feb 4, 2021 with the price of 22.20 HKD, and its all-time low was 0.58 HKD and was reached on Sep 9, 2024. View more price dynamics on 2160 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2160 stock is 4.41% volatile and has beta coefficient of 1.80. Track MICROPORT CARDIOFLOW MEDTECH CORP stock price on the chart and check out the list of the most volatile stocks — is MICROPORT CARDIOFLOW MEDTECH CORP there?
Today MICROPORT CARDIOFLOW MEDTECH CORP has the market capitalization of 1.66 B, it has increased by 2.94% over the last week.
Yes, you can track MICROPORT CARDIOFLOW MEDTECH CORP financials in yearly and quarterly reports right on TradingView.
MICROPORT CARDIOFLOW MEDTECH CORP is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
2160 net income for the last half-year is −61.18 M HKD, while the previous report showed −315.60 M HKD of net income which accounts for 80.61% change. Track more MICROPORT CARDIOFLOW MEDTECH CORP financial stats to get the full picture.
No, 2160 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 592.00 employees. See our rating of the largest employees — is MICROPORT CARDIOFLOW MEDTECH CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICROPORT CARDIOFLOW MEDTECH CORP EBITDA is −167.14 M HKD, and current EBITDA margin is −67.52%. See more stats in MICROPORT CARDIOFLOW MEDTECH CORP financial statements.
Like other stocks, 2160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICROPORT CARDIOFLOW MEDTECH CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICROPORT CARDIOFLOW MEDTECH CORP technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICROPORT CARDIOFLOW MEDTECH CORP stock shows the sell signal. See more of MICROPORT CARDIOFLOW MEDTECH CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.